IMMUNIZATION EXPERIMENTS WITH SWINE INFLUENZA VIRUS by Shope, Richard E.
IMMUNIZATION  EXPERIMENTS  WITH  SWINE  INFLUENZA 
VIRUS 
Bx RICHARD E. SHOPE, M.D. 
(From the Department of Animal and Plant Pathology of The Rockefeller Institute  for 
Medical Research, Princeton, N. J.) 
(Received for publication,  April 10, 1936) 
In earlier experiments (1)  it was shown that swine influenza virus, 
administered  intramuscularly,  immunized  pigs  to  swine  influenza 
and achieved this result without inducing evidence of iv_fection.  It 
was pointed out that this method of immunization might be of practi- 
cal value. 
The  discovery by Smith,  Andrewes,  and Laidlaw that ferrets  (2) 
and mice (3)  are also susceptible to swine influenza virus has made it 
possible  to  compare  the immunity produced  by various methods in 
these small animals with that similarly produced in the natural host. 
The present experiments were conducted in an effort to determine the 
effect of dosage, route of administration, and animal source upon the 
efficacy of  swine  influenza virus  in  immunizing swine,  ferrets,  and 
mice. 
EXPERIMENTAL 
Preparalion  of Virus Jot  Use as  Vaccine 
The strain 15 (Iowa,  1930) swine influenza virus was used in all experiments. 
It will be designated swine, ferret, or mouse virus in this paper to indicate its 
immediate ani~mal  source and the only species other than swine through which it 
has passed.  All mouse virus used had been transferred serially at least five times 
in mice, and all ferret virus at least fifteen times in ferrets. 
To prepare  virus for use as vaccine, weighed amounts of infected lung which 
had been in glycerol in the refrigerator  for from 3 days to a month were ground 
with sand to make 5 per cent suspensions in physiological salt solution.  These 
were allowed to sediment for 10 minutes and the supernatant fluid removed by 
pipette was employed as the vaccine.  All virus suspensions were prepared on the 
day on which they were to be used. 
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Titration of Swine Influenza Virus Used to Vaccinate 
The approximate number of mouse-infecting doses of virus per cubic centimeter 
of vaccine was estimated  in some of the experiments.  While these figures are not 
exact,  they furnish  an idea of the relative  amounts of virus administered  during 
the period of immunization.  They were obtained as follows: Etherized mice were 
inoculated  intranasally as previously  described  (4)  with  dilutions  of 5 per cent 
virus suspensions, ranging at intervals  of 10, to 1:10,000.  3 or 4 mice were in- 
oculated  with each dilution.  All mice surviving on the 6th day were killed with 
chloroform and their lungs, as well as the lungs of those which died earlier, were 
examined  for influenzal lesions.  The highest  dilution  of  virus  causing  definite 
lung lesions in one or more mice inoculated  was taken as the virus titer.  From 
this the number of mouse-infecting doses of virus per cubic centimeter of 5 per cent 
suspension  was calculated  on the assumption  that approximately 0.1  cc.  (4)  of 
suspension entered  the respiratory tract of each mouse inoculated.  Thus a sus- 
pension  whose highest  infectious  dilution  was  1:100 would  contain  100 mouse- 
infecting doses of virus for each 0.1 cc. or 1000 per cc.  These approximate  values 
are recorded in two of the following tables. 
Active Immunization of Swine to Swine Influenza 
While it was known that swine virus administered intramuscularly 
actively immunized swine to swine influenza (1), it seemed of interest 
to determine whether ferret  virus and mouse virus would achieve a 
similar result. 
A number of swine were given two subcutaneous  or intramuscular inoculations, 
8 days apart, of swine influenza virus from various  animal  sources.  They were 
tested for immunity to swine influenza 15 or 33 days after their last immunizing 
dose of virus by the intranasal instillation  of a mixture of swine influenza virus and 
tt. influenzae suis (5).  Mter a 4 day observation period following the immunity 
test,  during which their temperatures  were recorded morning and evening,  they 
were killed by chloroforming or bleeding.  Their respiratory tracts were examined 
at autopsy for lesions of influenza and the lungs, and in some cases turbinates,  were 
tested for virus by inoculation  into mice.  Blood serum  obtained from each pig 
before and after immunization  was tested in mice for virus-neutralizing  antibodies 
by a method already described (6).  The results of the immunization  experiments 
in swine are given  in Table I. 
As shown in Table I, 7 swine which received intramuscular or sub- 
cutaneous  injections  of  swine  influenza  virus  from  ferrets,  mice, 
or  swine  were  found  immune  to  swine  influenza  when  tested  later 
by intranasal inoculation with a  mixture of swine influenza virus and 
H. influenzae suis (5).  2 control swine similarly inoculated developed RIC.ttAILD  E.  SttOP:E  49 
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swine influenza that was typical both clinically and at autopsy.  The 
ferret  and  mouse viruses appeared  to be as effective in immunizing 
swine as was that derived from swine. 
No virus could be demonstrated in the lungs of the 6 swine tested 
although  it was found in the  turbinates  of  one  of  them.  Previous 
experiments have shown that virus is regularly and abundantly present 
in  the  turbinates,  tracheal  exudate,  and  lungs  of  susceptible  swine 
killed on the 3rd or 4th day of an influenza infection  (7).  The im- 
munized  animals were thus not only refractory to infection but had 
also, with one exception, inactivated or destroyed the virus adminis- 
tered  in  testing  for  immunity.  In  the  exceptional  animal,  virus 
established itself in the nose but failed to invade the lung. 
Antibodies neutralizing  swine influenza virus appeared in the sera 
of all animals during the course of immunization.  It was estimated, 
without recourse to titration, that these were of lower titer than those 
resulting from an attack of the disease. 
A ctive Immunization of Ferrets 
Smith, Andrewes, and Laidlaw (8) attempted to immunize ferrets to 
swine and to human influenza virus by repeated subcutaneous injec- 
tions of each virus.  According to a  personal communication, ferrets 
were the immediate animal source of the virus used.  Of the 11 ferrets 
included in their experiments, 2 were found completely resistant later 
to the test dose of virus given by intranasal or intrapulmonary  inocu- 
lation under ether narcosis.  The remaining animals developed either 
nasal symptoms or fever much like the controls.  They differed from 
the controls, however, in that they showed no lung lesions at autopsy. 
It was concluded that in these animals a partial immunity, sufficient 
to protect the lungs from virus attack,  had been established. 
In the present experiments an attempt was made to immunize fer- 
rets to swine influenza  virus by the subcutaneous or intraperitoneal 
injection of ferret, mouse, or swine virus. 
2 cc. doses of 5 per cent infected lung suspension were administered either once 
or twice, at 8 day intervals, to each ferret.  The animals were tested for immunity, 
15 to 41 days after their last immunizing injection, by intmnasal inoculation under 
ether narcosis with 1 cc. of a 5 per cent suspension of swine influenza virus derived 
from ferret lung.  After an observation period of from 4 to 7 days following the RICHARD  E.  SHOPE 
TABLE  II 
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immunity test, during which  their  temperatures were recorded morning and eve- 
ning, they  were killed by chloroforming.  Their respiratory tracts were examined at 
autopsy for evidence of infection  (9) and in some cases the turbinates and lungs 
were tested for virus by inoculation  into mice.  The results  of attempts to im- 
munize ferrets  to swine influenza virus are given in Table II.  The experiments 
included were not all conducted simultaneously. 
As shown in Table II, 8  of 9  ferrets that had received one or two 
subcutaneous injections of ferret virus were rendered immune to swine 
influenza virus.  Little if any immunity, however, was established by 
the  similar  administration  of swine  or  mouse  virus.  6  ferrets  that 
had received either one or two injections of swine virus, and 4 ferrets 
that had received one or two injections of mouse virus subcutaneously, 
were  not  immune  and  differed  little  or  not  at  all from  the  control RICHARD E. &HOPE  53 
animals with respect to illness and  lung lesions exhibited following their 
test infection.  One ferret  (No.  9-7)  that had received two subcu- 
taneous injections of mouse virus  developed an  influenza that  ap- 
peared typical clinically, but at autopsy its lungs were normal.  Iris 
apparent  from  the  above  experiments  that,  when  given  subcuta- 
neously, ferret virus is superior to that from either mice or swine in 
immunizing ferrets  to  swine  influenza  virus.  No  reason  for  this 
superiority of homologous over heterologous virus is evident. 
The advantage of ferret  over swine or mouse virus was less  ap- 
parent when the immunizing inoculations were given intraperitoneally. 
All 3 ferrets that had received mouse virus into the peritoneal cavity 
and 2 of 3 of those similarly inoculated with swine virus were rendered 
clinically  immune  to  swine  influenza  virus.  These  experiments 
indicate that the route by which heterologous swine influenza virus is 
administered to ferrets determines, to a marked degree, its effective- 
ness in producing immunity. 
The results of the tests for virus in the turbinates and lungs of a 
number of the ferrets, given in the last column of Table II, indicate 
that  the  lungs  of  immunized animals,  which  appeared  normal  at 
autopsy, were also free from detectable virus.  However, the turbi- 
nates of some of the ferrets that had shown no clinical symptoms con- 
tained sufficient virus to infect mice.  It is probable that these ferrets 
had been less effectively protected than those in which virus failed to 
become established in the turbinates following the test for immunity. 
The  14 ferrets in Table  II which showed varying degrees of im- 
munity may be grouped into three classes:  those immune and free from 
demonstrable virus; those immune which had virus in the turbinates, 
and the single ferret (No. 9-7)  which, though not clinically immune, 
developed no lung lesions and had virus only in its turbinates.  The 
majority of ferrets in the experiments reported by Smith, Andrewes, 
and Laidlaw (8) would belong in the last group. 
Active Immunization o/ Mice 
Smith, Andrewes, and Laidlaw  (8),  and Francis and Magi]/  (I0) 
have reported the immunization of mice to human influenza virus by 
means of repeated doses of virus given subcutaneously, intradermally, 
or intraperitoneaUy, or by a combination of these routes. 54  IMMUNIZATION WITH  SWINE  INFLUENZA  VIRUS 
The following experiments were conducted in an effort to define the 
conditions required for the immunization of mice to swine influenza 
virus.  Preliminary experiments  had  suggested  that  mice  behaved 
towards  homologous and  heterologous swine influenza virus much as 
did the ferrets described in the preceding section.  It seemed likely, 
therefore,  that  the  question  of  immunization  with  swine  influenza 
virus from various  animal  sources could be investigated more thor- 
oughly in mice than in ferrets.  Moreover, since the infection produced 
by swine influenza virus in mice is both highly fatal and noncontagious 
(4),  the  efficacy of immunization procedures in  this  species may be 
determined by survival alone and  the  extreme isolation precautions 
essential with ferrets or swine are unnecessary. 
Mice 3 to 5 weeks old and weighing from 10 to 15 gin. at the beginning of the 
immunization procedure were  used.  0.2  cc. doses  of 5 per cent infected lung 
suspension were administered,  either once, or repeatedly at 8 day intervals, to each 
mouse subcutaneously or intraperitoneally as recorded in Table III.  The animals 
were tested for immunity to mouse lung swine influenza virus (either a 2 per cent or 
5 per cent suspension)  administered intranasally under ether narcosis (4) 14 or 30 
days after their last immunizing dose of virus.  The control mice, acquired from 
stock at the same time as those to be vaccinated and kept in the same isolation 
room, quite regularly succumbed  to this amount of virus within 7 days.  All mice 
dying were autopsied in order to establish  that death had been the result of an 
influenza  virus pneumonia.  Survival was  taken as  the criterion of immunity. 
The results of attempts to immunize  mice to swine influenza  virus by various 
procedures are recorded in Table III. 
The four experiments presented in Table III are not strictly comparable for, 
while the amount of infected lung suspension used to vaccinate was kept constant, 
the virus content of these suspensions  varied from approximately 100 to 10,000 
mouse  infecting  doses  per  cc.  Within  individual  experiments,  however,  the 
results reflect  quite clearly the effectiveness  of one immunization procedure as 
compared with others in  the same experiment, and even between experiments 
certain broad comparisons  can be made.  Of 83 control mice infected in the four 
experiments, 79 died, indicating the virulence of the virus and the severity of the 
test for immunity. 
Swine  virus  administered  subcutaneously  was  definitely the  least 
effective of any of the immunization procedures tried; only 5 of 63 mice 
(8 per cent)  thus  treated survived the test dose of virus and  these 5 
survivors were all in Experiment 4  in which an unusually virus-rich TABLE  III 
The Immunization ~  Mice to Swine Influenza  Virus 
Experiment 
No. 
Vaccina~on 
Source of 
virus 
Swine 
Ferret 
Mouse 
~c 
No. and route of inoculations 
(each inoculation  0.2 cc.) 
2--subcutaneous 
2--  t~ 
2--intraperitoneal 
2--subcutaneous 
1--  st 
2--  " 
(diluted 1:10) 
Mice recovered from intranasal infection 
with swine virus 
Unvaccinated control mice 
Swine  2--intraperitoneal 
Ferret  2--  " 
Mouse  2--  " 
"  2--  " 
(diluted (1 : 10) 
Mice recovered from intranasal  infec- 
tion with swine virus 
Unvaccinated control mice 
Swine  3--subcutaneous 
"  3--intraperitoneal 
Mouse  3---subcutaneous 
"  3~intraperitoneal 
Unvaccinated control mice 
Swine  3--subcutaneous 
"  3--intraperitoneal 
Mouse  3--subcutaneous 
"  3--intraperitoneal 
"  1--subcutaneous 
"  1--intraperitoneal 
"  3--subcutaneous  (with  10 
per cent swine serum) 
"  3--intraperitoneal (with 10 
per cent swine serum) 
"  3--subcutaneous  (diluted 
1110) 
"  3--intraperitoneal  (diluted 
1:10) 
Unvaccinated control mice 
infecting 
doses of 
virus per cc. 
1000 
1000 
1000 
1000 
1000 
100 
100 
100 
1000 
100 
100 
100 
100 
100 
10,000 
10,000 
10,000 
10,000 
10,000 
10,000 
10,000 
10,000 
1000 
1000 
Interval 
between last 
inoculation 
and immunity 
test 
days 
3O 
30 
3O 
30 
30 and 38 
30 
14 
14 
14 
14 
14 
14 
14 
14 
14 
14 
14 
14 
30 
30 
14 
14 
14 
14 
Results of 
tests for 
immunity 
0/19" 
3/18 
8/10 
6/12 
9/19 
3/16 
8/8 
o/19 
11/18 
12/20 
10/18 
11/20 
6/6 
1/2o 
0/20 
8/18 
11/14 
to/t1 
2/20 
5/24 
23/24 
19/23 
21/21 
11/24 
12/25 
16/18 
21/23 
15/24 
13/23 
1/24 
* The  numerator  represents  the number  of mice that  survived the  immunity 
test; the denominator the number of mice in the group tested. 
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vaccine had been employed.  Ferret virus given subcutaneously also 
failed to induce an appreciable degree of immunity. 
Swine virus given intraperitoneally, on the other hand, produced a 
fair degree of immunity; 42 of 60 mice (70 per cent) thus treated sur- 
vived the test dose of virus.  In Experiment 4, in which a swine lung 
vaccine rich in virus had been used, 23 of 24 mice survived.  Ferret 
virus was also a better immunizing agent when given intraperitoneally, 
20 of 30 mice (66 per cent) thus treated surviving the immunity test. 
Mouse virus administered two or three times proved the best im- 
munizing agent for mice and the intraperitoneal route held only a slight 
advantage over the subcutaneous route.  36 of 49 mice (73 per cent) 
that had received mouse virus subcutaneously and 41 of 50 mice (82 
per  cent)  that  had  received it  intraperitoneally  survived  the  test 
infection.  Single  injections  of  mouse  virus  given  either  subcu- 
taneously  or  intraperitoneally  produced  an  immunity  that  was 
inferior to  that  following multiple injections.  Only  17  of 43  mice 
(40 per cent) that had received a single subcutaneous dose of mouse 
virus and 12 of 25 mice (48 per cent) that had received a single intra- 
peritoneal injection survived the test dose of virus.  The importance 
of dosage of virus administered in establishing immunity is indicated by 
the  two  groups  of  mice receiving multiple  inoculations  of  0.2  cc. 
amounts of 0.5 per cent instead of the usual 5 per cent mouse virus. 
Only 18 of 40 mice (45 per cent) receiving multiple injections of this 
dilute virus subcutaneously and 24 of 43 mice (56 per cent) receiving 
it  intraperitoneally survived the  test  dose  of  virus.  From  this  it 
would appear that multiple injections of 0.5 per cent mouse virus were 
only slightly, ff at all, superior to single injections of 5 per cent mouse 
virus in immunizing mice. 
Laidlaw and Dunkin (11) suggested that the multiplicity of antigens 
contained in heterologous dog distemper vaccine interfered with the 
antibody  response  to  formolized virus  and  thus  accounted for  its 
inability  to  immunize.  It  seemed  possible  that  this  explanation 
might also account for the failure of swine virus given subcutaneously 
to immunize mice to swine influenza virus.  However, the addition of 
normal  swine serum  to  mouse  virus  did  not  appreciably  alter  it~ 
capacity to immunize mice (Experiment 4 of Table III), suggesting 
that some more complex explanation was applicable here. RICHARD  E.  SHOPE  57 
Risk of Infeaion during Immunization  with Swine Influenza  Virus 
A  small number of mice succumbed during the period they were re- 
ceiving their immunizing injections  of swine influenza  virus.  These 
were carefully autopsied in an effort to determine the cause of death. 
In most instances intestinal infections with an accompanying diarrhea 
were  responsible.  In  a  few,  however,  pneumonia  was  encountered. 
The lungs of such animals were tested for the presence of swine influ- 
enza  virus by mouse  inoculation,  but  in  no  instance  was it  demon- 
strated.  None of the ferrets or swine became ill during the course of 
immunization and their temperatures, recorded daily, remained within 
normal limits.  The present experiments thus afford no evidence that 
the  administration  of  swine  influenza  virus  subcutaneously,  intra- 
peritoneaUy, or intramuscularly,  entails any risk of infection. 
Experience  in  some  unpublished  immunization  experiments  con- 
ducted among swine on farms in eastern Iowa, however, suggests that 
under certain conditions immunization with swine influenza virus may 
be a hazardous procedure. 
In the field experiments referred to, 1635 swine on 55 different Iowa farms were 
given one or more intramuscular injections of glycerolated swine influenza, virus. 
3603 other swine on these same farms were left uninoculated to serve as controls 
should an epizootic of swine influenza  later appear.  Wherever feasible the vac- 
cinated swine were kept isolated from the remainder of the drove for a period of 
from 10 days to 2 weeks.  In a number of instances, however, there were no facili- 
ties for isolation and it was necessary to keep the inoculated swine in the same 
yards with uninoculated animals.  In two such droves swine influenza  appeared 
shortly after swine  influenza  virus had been administered intramuscularly to a 
portion of the animals. 
Drove 1 contained 223 swine.  Early in August, 12 days after 23 of these ani- 
mals had received an intramuscular injection of swine influenza  virus, swine  in- 
fluenza appeared in the drove.  On the 4th day following onset all save 30 animals 
were typically ill of influenza.  Among these 30 apparently normal swine  were 
20 of the 23 that had received virus intramuscularly 16 days earlier.  So far as 
could be determined, there was, at the time, no other swine influenza in eastern 
Iowa to which this outbreak could be traced.  Furthermore, it was early August, 
fully 2 months before swine influenza  ordinarily becomes prevalent in the Middle 
West.  The length of time (12 days) elapsing between vaccination and the appear- 
ance of disease in the swine eliminated from consideration the possibility that they 
had become infected by virus accidentally spilled in the yards at the time of vac- 
cination.  The most probable source of infection seemed to be the animals to 58  IMMUNIZATION WITH  SWINE  INlVLUENZA VIRUS 
which swine  influenza  virus had  been administered intramuscularly.  It is be- 
lieved, although it cannot be proved from the data at hand, that virus spread from 
the intramuscular site of inoculation and invaded the respiratory tract of one or 
more of these animals.  From here it was transmitted rapidly by contact among 
the 200 susceptible swine in the drove.  Either the swine first infected, or some of 
those to which the virus was transmitted very early, must have been carriers of 
H.  influenzae  suis for the disease developing in  the drove was swine  influenza 
(caused by the combined action of virus and H. influenza* suis (5)), and H. in- 
fluenzee suis was recovered from the pneumonic lung of one of the fatal cases.  20 
of the 23 vaccinated animals failed to develop influenza at the time the remainder 
of the herd became ill, probably because the 12 days elapsing between their inocu- 
lation and the outbreak of the disease had been sufficient for the establishment of 
immunity.  There is considerable likelihood,  based on experience with droves in 
which  inoculated animals were kept isolated for 2 weeks after vaccination, that 
had the 23 vaccinated animals in this herd been kept separate from the 200 non- 
inoculated swine, no illness would have appeared in either group of animals. 
The second drove, in  which influenza  appeared shortly following  the  intra- 
muscular administration of swine influenza  virus, contained  195 swine.  4 days 
after 95 of these animals had been vaccinated, influenza  appeared in the drove. 
So far as could be observed all animals became ill.  The source of infection is 
believed similar to that in drove 1, although here the interval between injection 
and onset of illness was so short that infection from premises contaminated with 
virus at the time the animals were inoculated could not be eliminated.  Insufficient 
time had elapsed for the development of immunity in  the vaccinated animals 
although the owner was of the opinion that the first cases appeared in unvaccinated 
swine.  As in the case of drove 1, this outbreak occurred in August, but a year 
later, and it could not be traced to an outside source of infection. 
The swine influenza in  the  two herds  just  discussed  is believed to 
have been caused by the virus used to vaccinate.  The examples cited 
are considered illustrative of the hazard entailed in the introduction of 
a  "live" virus vaccine into only a  portion  of  a  densely  crowded sus- 
ceptible population.  To judge from the laboratory experiments with 
mice, ferrets, and swine and the field experiments with swine, the use 
of  "live" swine  influenza  virus  as  a  prophylactic  agent  may be less 
dangerous to the recipient of the virus than it is to other susceptible 
individuals  with  which  the  recipient  may  come in  contact  during 
the  course of immunization. 
DISCUSSION 
The immunization  experiments described indicate  that ferrets and 
mice are similar in  their reactions  towards  swine influenza  virus ad- ~I~  E. SHOPE  59 
ministered as a vaccine.  With both species only the homologous virus 
proved  an  effective immunizing agent when given subcutaneously; 
ferret or swine virus given by this route to mice, and mouse or swine 
virus similarly administered to ferrets, established little or no active 
immunity.  These failures were not due to inability of swine influenza 
virus to immunize when introduced into subcutaneous tissues, because 
the homologous virus, given by this route, proved effective in both 
ferrets and mice.  Neither were they entirely the fault of the virus 
suspensions employed because the heterologous virus immunized al- 
most as well as the homologous when given intraperitoneally. 
In the case of swine the route of inoculation or the source of the virus 
used to vaccinate was of little importance, for active immunity fol- 
lowed subcutaneous or intramuscular injection of either homologous 
or heterologous virus. 
The mechanism whereby swine influenza virus, introduced intra- 
peritoneally, intramuscularly, or  subcutaneously succeeds in estab- 
lishing an immunity capable of protecting the highly susceptible tissues 
of the respiratory tract is unknown.  Specific virus-neutralizing anti- 
bodies resulting from vaccination may contribute to the immunity, 
although they can  scarcely be held entirely responsible since their 
presence  is  not  necessarily synonymous with  complete  active  im- 
munity, as shown by Smith, Andrewes, and Laidlaw (8).  A possibility 
which may be entertained only to be discarded is that virus spreads 
from the site of inoculation to the respiratory tract in minute quan- 
tities  insufficient  to  produce clinlcally recognizable disease but  re- 
sulting in subclinical infections and  subsequent immunity.  Against 
this possibility are two observations brought out in the present experi- 
ments: the superiority, as immunizing procedures, of multiple over 
single virus injections, and the superiority of homologous over heter- 
ologous virus  given  subcutaneously.  If  immunity were merely the 
result  of  subclinical infection, it is  not apparent  why it  should be 
greatly influenced by number of injections, route of inoculation, or 
animal  source  of  virus  administered.  The  above  arguments  are ' 
effective in the cases of the mouse and the ferret.  They may not, how- 
ever, apply to swine for, with this species, virus from any susceptible 
host  administered either subcutaneously or intramuscularly confers 
immunity and the evidence of earlier experiments (1) indicates that a 60  IMMUNIZATION  WITH  SWINE  INFLUENZA  VIRUS 
single intramuscular injection of virus is sufficient to immunize effec- 
tively.  In spite of the absence of good evidence to the contrary, there 
is little to indicate that swine influenza virus given intramuscularly to 
swine, regularly induces immunity by  virtue of its invasion of the 
respiratory tract and its establishment there of a low grade and un- 
recognized infection.  The two droves of swine mentioned, in which 
influenza appeared shortly after virus had been administered intra- 
muscularly, probably acquired their infections from virus used in the 
attempted  immunization.  They  thus  afford  evidence  that  under 
certain  conditions the  virus  may  spread  to  the  respiratory  tract. 
However, they probably represent exceptional instances, because none 
of the swine investigated under laboratory conditions showed evidence 
of illness during immunization and over 1300 animals vaccinated in 
field experiments remained normal.  It thus seems likely that swine, 
as well as ferrets and mice, can acquire an immunity to swine influenza 
virus  following its  administration  by  unusual  routes,  without  the 
actual infection of tissues in which it causes disease manifestations. 
SUM-~AR¥ 
1.  Swine influenza virus obtained from the lungs of infected ferrets 
or mice, when adm~uistered intramuscularly or subcutaneously, im- 
munizes swine to swine influenza. 
2.  Ferrets,  which have received subcutaneous injections of swine 
influenza virus obtained from the lungs of infected ferrets, are immune 
to intranasal infection with this virus.  Similar injections with virus 
from the lungs of infected mice or swine do not immunize. 
3.  Mice can be immunized to intranasal infection with swine in- 
fluenza virus by the subcutaneous injection of virus obtained from the 
lungs of infected mice, but not by similar injection with virus from the 
lungs of infected ferrets or swine.  Repeated injections induce greater 
immunity than a single one. 
4.  Intraperitoneal inoculation of both mice and ferrets with swine 
influenza virus immunizes them to intranasal infection and it appears 
to make little or no difference whether the virus used as vaccine is 
obtained from the lungs of infected mice, ferrets, or swine. 
3.  Field experiments in which swine influenza followed the intra- 
muscular administration of virus are cited as examples of the hazard RICHARD E.  SHOPE  61 
involved in the use of this means of immunization in a densely crowded 
susceptible population. 
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